Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Receivables: 2010-2024

Historic Receivables for National Research (NRC) over the last 15 years, with FY2024 value amounting to $11.2 million.

  • National Research's Receivables rose 1617.89% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 1617.89%. This contributed to the annual value of $11.2 million for FY2024, which is 980.58% down from last year.
  • As of FY2024, National Research's Receivables stood at $11.2 million, which was down 980.58% from $12.5 million recorded in FY2023.
  • National Research's Receivables' 5-year high stood at $14.6 million during FY2022, with a 5-year trough of $11.2 million in FY2024.
  • Moreover, its 5-year median value for Receivables was $13.8 million (2021), whereas its average is $13.3 million.
  • Its Receivables has fluctuated over the past 5 years, first soared by 2122.3% in 2020, then tumbled by 1442.7% in 2023.
  • Annual analysis of 5 years shows National Research's Receivables stood at $14.2 million in 2020, then fell by 2.86% to $13.8 million in 2021, then rose by 5.32% to $14.6 million in 2022, then dropped by 14.43% to $12.5 million in 2023, then dropped by 9.81% to $11.2 million in 2024.
  • Its Receivables stands at $11.2 million for FY2024, versus $12.5 million for FY2023 and $14.6 million for FY2022.